Brief: Exagen Inc Announces Study On The Long-Term Effects Of Covid-19 Infection
March 29 (Reuters) - Exagen Inc XGN.O :
* EXAGEN INC. ANNOUNCES STUDY ON THE LONG-TERM EFFECTS OF
COVID-19
INFECTION IN THE DEVELOPMENT OF AUTOIMMUNE DISEASES
* EXAGEN INC - LONGITUDINAL STUDY WILL FURTHER EVALUATE
EMERGENCE
OF BIOMARKERS THAT ARE KNOWN INDICATORS FOR DEVELOPMENT OF
LUPUS, RHEUMATOID ARTHRITIS
Source text for Eikon: ID:nGNX4JC7v0
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance